Excision of pulmonary metastases secondary to colorectal carcinoma, in the absence of extrathoracic metastatic disease, has been shown to improve long-term survival rates",. The technique of precision excision of metastases allows for removal of multiple metastases without loss of extensive pulmonary volume3. We review the course of a patient on whom this procedure was carried out and highlight its usefulness in a select group of patients.
Case report A 60-year-old woman was treated by anterior resection for a Dukes B moderately differentiated rectal carcinoma in March 1986. A defunctioning transverse colostomy was fashioned because of the low level of the resultant anastomosis. A routine chest X-ray 5 months later, following admission for colostomy closure, demonstrated metastatic disease in the left lung. A subsequent CT scan confirmed the presence of 3 pulmonary metastases on the left side and 2 further lesions in the right lung. No evidence of extrathoracic disease was detected at this stage. Excision ofthese metastases, via a median sternotomy, was perfd using a diathermy probe to remove the metastatic nodules with a margin of approximately 10 mm of normal lung tissue. The resultant pulmonary defects were over with catgut. The postoperative period was uncomplicated and the patient was discharged home 15 days after the operation. Histology confirmed the lesions to be consistent with metastases from the previously resected rectal carcinoma. This patient remains well and a CT scan at 4 months and repeated chest X-rays up to 15 months have been normal.
Discussion
The presence of pulmonary metastases associated with primary colorectal carcinoma, synonomous with group D of Dukes classification, is generally acknowledged to indicate a poor prognosis. In view of recent evidence suggesting improved 5 year survival figures following excision of pulmonary metastases in the absence of other metastatic disease', a small minority of patients with primary colorectal cancer would appear to be suitable for such treatment. A recent review estimated that approximately 1% of all patients with colorectal carcinoma will develop isolated pulmonary metastases following resection of the primary tumour4. Rectal and rectosigmoid tumours are most often associated with isolated pulmonary metastases and this is thought to result from early involvement of the middle rectal veins leading to invasion of the systemic venous system2. The importance of routine follow-up chest X-rays is supported by evidence that up to 75% ofpulmonary secondaries will be detected by this simple investigation1.
Further investigation to outrule extrathoracic disease is then essential before excision of metastases is contemplated. Excision of pulmonary metastases has been performed in various centres for many years. This traditionally took the form of pneumonectomy, lobectomy and wedge resections. The technique of precision excision has only recently been described5. This allows for excision of greater numbers of metastatic nodules and for repeated thoracotomies if the patient returns with further isolated pulmonary disease, as loss of normal lung tissue is minimal. A median sternotomy allows for ease of access to both lungs if required.
The use of this method of pulmonary metastasectomy is assciated with low morbidity and mortality in surgical units with experience of chest surgeryl'. The improved longterm survival following such treatment in a select group of patients dictates the need for clinicians to be aware of the type of patient who may benefit from this therapy. The exclusion of extrathoracic metastatic disease is of utmost 0141-0768/89 020115-02402.00/0 ©1989 The Royal Society of Medicine importance. The smooth operative and postoperative course of the patient documented in this report further supports a role for pulmonary metastasectomy in the treatment of patients with colorectal carcinoma. Mycosis fungoides is a T-cell lymphoma which may present as eczematous or psoriasiform lesions, generalized plaques, erythroderma or nodular ulcerating lesions. In early stage disease non-specific histological features are frequently seen which are not pathognomonic. Although the tumour usually remains confined to skin for many years, lymph node and visceral involvement may occur as late events and are a frequent postmortem finding1. We report a case of mycosis fungoides who, following successful treatment for extensive cutaneous disease, developed CNS involvement without detectable visceral extension.
Case report A 53-year-old male gave a 4 year history of an itchy rash on his hand. In the year prior to presentation the rash had extended to form erythematous plaques and patches involving the whole integument. The interpretation of several skin biopsies proved difficult showing features of psoriasiform hyperplasia, psoriasiform eczema or erythroderma. However, a confident clinical diagnosis of mycosis fungoides was made. Despite PUVA therapy the disease progressed to form widespread marginated erythematous and infiltrated areas. A further biopsy showed a dermal infiltrate primarily containing cells of the lymphoid series with cytological atypia. No Pautrier abscess formation was seen but the appearances were considered consistent with partially treated mycosis fungoides. Topical nitrogen mustard and UVB therapy were poorly tolerated and the patient was lost to follow-up for 18 months.
He was next reviewed in July 1986 when more extensive plaque and tumour stage disease was present. Further investigations, which included a lymph node biopsy, bone marrow examination, chest X-ray and computed tomography, were all negative. As the disease remained confined to the skin, whole body electron therapy was given with a good response (3000 cGy in 10 fractions over 35 days) and PUVA treatment was also recommenced.
In April 1987 the patient complained of a persistent pyrexia and lethargy. The white cell count was 16.6x iO0fl (polymorphs 87%, lymphocytes 4%, eosinophils 7%) and erythrocyte sedimentation rate 89. No focus of infection was evident and despite screening cultures being sterile, the pyrexia slowly resolved following a course ofbroad spectrum antibiotics. A whole body CT scan was again normal.
The symptoms recurred within 4 weeks of discharge and on this occasion Staphylococcus aureus was isolated from the skin and in one blood culture; intravenous flucloxacillin and gentamicin were given. The patient remained unwell and 9 days later became acutely confused and had a grand mal fit; no neck stiffness or abnormal focal neurological signs were present and the fundi were normal. An enhanced cerebral CT scan showed no abnormality. A lumbar puncture was performed. The cerebrospinal fluid was clear with a pressure of 140 mm ofwater (protein content 0.6 gll, glucose 2.7 mmol/l, red blood cell 60/mm3, white blood cell 42/mm3). Microscopy, culture, auramine stains, indian ink stains and viral serology were all negative. Cytospin preparations, using Romanovsky stain, showed an abnormal immunophenotype consistent with a T-cell lymphoma comprising CD7 (3A1) positive, CD2 (OKT,1) positive, CD3 (OKT3) negative, CD4 (OKT4) negative, CD8 (OKT8) negative and CD19 (Pan-B) negative.
Despite treatment with diazepam, the patient developed status epilepticus. Phenytoin, carbamezepine and chlormethiazole proved ineffective and the fits were finally controlled with thiopentone whose use necessitated a short period of ventilation. Whole brain irradiation (3000 cGy), intrathecal methotrexate and cytosine arabinoside were given. A modest improvement in the patient's condition was seen over several days. However, a further rapid deterioration occurred and death ensued within a week of completing treatment.
In the National Cancer Institute review' of mycosis fungoides, most patients presented with non-specific eczematous or 'psoriasiform' eruptions23 and in 50% of cases the diagnosis was only confirmed patho-logically with the development of cutaneous tumours, ulcers or palpable lymph nodes. The presence of Pautrier abscess formation, although a feature of mycosis fungoides, is not a prerequisite for the diagnosis and was absent in 15 of 44 cases reviewed by Rappaport and Thomas4.
Visceral involvement is seen in 50% ofpatients dying with tumour stage diseasel4'5 and when overt is associated with a mean survival of less than 1 year" 5-7. The principal sites of involvement include the lymph nodes (75%), lung (66%), liver (53%) and spleen (60%)1"4 8 although multiple organs are frequently affected'. Despite such widespread dissemination, however, the predominant cause of death in these patients is septicaemia or bacterial pneumonia with Staphylococcus aureus and Pseudomonas aeruginosa being most frequently cultured6'9.
Although visceral involvement is well recognized, clinically detectable CNS disease has only been reported infrequently'0-'5. However, postmortem studies have demonstrated both cerebral and meningeal disease. In one series of 144 patients', 11% had CNS involvement from which the death of 4 patients resulted. Lundberg'5 reported an interesting case of leptomeningeal involvement in whom a 7 month remission was induced with chemotherapy. However, despite very similar treatment in this case only a very tenuous response was seen. 0141-0768/89/ 020116-02/$02.00/0 @1989 The Royal Society of Medicine
